Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost‐effectiveness analysis utilising AFFIRM‐AHF-Reference-Cited by-同舟云学术

Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost‐effectiveness analysis utilising AFFIRM‐AHF

Published:2021-06-30 Issue:10 Volume:23 Page:1687-1697
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

McEwan Phil¹,Ponikowski Piotr²,Davis Jason A.¹,Rosano Giuseppe³,Coats Andrew J.S.⁴,Dorigotti Fabio⁵,O'Sullivan Donal⁵,Ramirez de Arellano Antonio⁵,Jankowska Ewa A.²

Affiliation:

1. Health Economics and Outcomes Research Ltd Cardiff UK

2. Department of Heart Diseases Wrocław Medical University Wrocław Poland

3. Cardiovascular and Cell Sciences Research Institute St George's University London UK

4. University of Warwick Warwick UK

5. Vifor Pharma Glattbrugg Switzerland

Funder

Vifor Pharma

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2270

Reference29 articles.

1. Epidemiology of heart failure

3. Quality of life of chronic heart failure patients: a systematic review and meta-analysis

4. The Global Health and Economic Burden of Hospitalizations for Heart Failure

5. A cost‐effectiveness analysis of ferric carboxymaltose in patients with iron deficiency and chronic heart failure in Spain;Comín‐Colet J;Rev Esp Cardiol,2015

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Iron Deficiency in Heart Failure;JACC: Heart Failure;2024-07

2. Expert recommendations for the management of iron deficiency in patients with heart failure in Asia;International Journal of Cardiology;2024-05

3. Effect of Ferric Carboxymaltose Versus Low-Dose Intravenous Iron Therapy and Iron Sucrose on the Total Cost of Care in Patients with Iron Deficiency Anemia: A US Claims Database Analysis;Drugs - Real World Outcomes;2024-03-19

4. Does patient blood management represent good value for money?;Best Practice & Research Clinical Anaesthesiology;2023-11

5. Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?;Current Heart Failure Reports;2023-07-10